Actively Recruiting

Phase 4
Age: 6Years - 40Years
All Genders
NCT04781972

Multimodal Brain Imaging of the Neural Effects of Methylphenidate in Patients With ADHD

Led by Johns Hopkins University · Updated on 2025-10-16

30

Participants Needed

1

Research Sites

404 weeks

Total Duration

On this page

Sponsors

J

Johns Hopkins University

Lead Sponsor

N

National Institutes of Health (NIH)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The investigators' goal is to develop neuroimaging biomarkers to predict response to treatment with methylphenidate, which then can be used in the development of novel pharmacological treatments for attention-deficit/hyperactivity disorder (ADHD). The overall objective of this study is to measure the changes in task-related neural activity related to symptoms of ADHD (measured by functional MRI) and brain glutamate levels (measured by magnetic resonance spectroscopy, MRS) after treatment with methylphenidate (MPH). This will be a double-blind crossover of methylphenidate and placebo in adults with ADHD. Participants will complete neuropsychological testing along with fMRI and MRS scans after a single dose of each treatment.

CONDITIONS

Official Title

Multimodal Brain Imaging of the Neural Effects of Methylphenidate in Patients With ADHD

Who Can Participate

Age: 6Years - 40Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Right handed
Not Eligible

You will not qualify if you...

  • Pregnant or breast feeding
  • Past or current neurological disorder
  • Non-ADHD cause of cognitive impairment
  • Uncontrolled medical disorder
  • Head trauma with loss of consciousness in the last year or any functional impairment after head trauma
  • Adverse reaction to methylphenidate or other stimulant medication
  • Contraindication to MRI
  • Current smoking

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Johns Hopkins School of Medicine

Baltimore, Maryland, United States, 21205

Actively Recruiting

Loading map...

Research Team

K

Kristin L Bigos, PhD

CONTACT

R

Robyn Wiseman, BS

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

BASIC_SCIENCE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here